FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC

Autor: Herbst, R., De Marinis, F., Giaccone, G., Vergnenegre, A., Barrios, C., Morise, M., Felip, E., Oprean, C., Kim, Y., Andric, Z., Mocci, S., Enquist, I., Komatsubara, K., Mccleland, M., Deng, Y., Kuriki, H., Villalobos, M., Phan, S., Spigel, D., Jassem, J.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S224-S225
Databáze: ScienceDirect